Product Description

Dihydrocodeine Tartrate

Dihydrocodeine Tartrate is a semi-synthetic opioid analgesic commonly prescribed for the management of moderate to severe pain. It is the tartrate salt form of dihydrocodeine, widely used in immediate-release tablets (such as 30mg strength) and prolonged-release formulations. It provides effective pain relief when non-opioid analgesics like paracetamol or ibuprofen are insufficient.

Often marketed under brands like DF118 Forte or as generics, Dihydrocodeine Tartrate is approximately twice as potent as codeine and works by acting on opioid receptors in the central nervous system.

Important Safety Note: Dihydrocodeine Tartrate is a controlled substance (Class B in the UK) and available only on prescription. It carries risks of dependence, tolerance, and respiratory depression. Use strictly under medical supervision and for the shortest duration necessary.

How Dihydrocodeine Tartrate Works

Dihydrocodeine Tartrate binds to mu-opioid receptors in the brain and spinal cord, reducing the perception of pain and producing mild sedative effects. Immediate-release forms typically start working within 1.5–2 hours and last 4–6 hours, while prolonged-release versions provide steady relief over 12 hours.

It may also be used for severe cough or shortness of breath in specific cases, though pain management is the primary indication.

Key Features and Benefits

• Effective Analgesia — Reliable relief for post-operative pain, injury, arthritis, or chronic conditions.
• Multiple Formulations — Immediate-release 30mg tablets and prolonged-release options (60mg, 90mg, 120mg).
• Proven Track Record — Long-established opioid with well-documented efficacy.
• Flexible Dosing — Can be tailored to individual pain levels under medical guidance.

Recommended Dosage (Adults)

• Immediate-release (30mg tablets): 30mg every 4–6 hours as needed. Maximum usually 240mg per day.
• Prolonged-release: 60–120mg every 12 hours (doctor-adjusted).
• Elderly patients or those with kidney/liver impairment require reduced doses.
• Always follow your prescriber’s instructions exactly. Do not crush or chew prolonged-release tablets.

Not suitable for children under 4 years (limited use 4–12 years) or certain high-risk groups.

Potential Side Effects

Common side effects include:

• Drowsiness and dizziness
• Constipation
• Nausea or vomiting
• Dry mouth
• Headache

Serious risks include respiratory depression, dependence, tolerance, and withdrawal symptoms upon sudden discontinuation.

Important Safety Information

• Addiction Risk: Long-term use can lead to physical and psychological dependence.
• Interactions: Avoid with alcohol, sedatives, or other CNS depressants.
• Driving: May impair alertness — do not drive or operate machinery if affected.
• Pregnancy/Breastfeeding: Generally contraindicated unless benefits outweigh risks.
• Purchase only from licensed pharmacies. Never buy from unregulated sources.

When to Consult a Doctor

Contact your healthcare provider if pain persists, worsens, or if you experience breathing difficulties, severe constipation, or signs of allergic reaction. A tapering plan is essential when stopping long-term treatment.

Dihydrocodeine Tartrate remains a valuable option for effective pain control when used responsibly under professional medical guidance.

Additional Information